Life [LIF] vs Procore Technologies [PCOR] Detailed Stock Comparison
Life
NASDAQ
Loading...
Procore Technologies
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Life wins in 7 metrics, Procore Technologies wins in 11 metrics, with 0 ties. Procore Technologies appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Life | Procore Technologies | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 229.47 | -89.09 | Procore Technologies |
| Price-to-Book Ratio | 55.29 | 8.15 | Procore Technologies |
| Debt-to-Equity Ratio | 84.50 | 5.94 | Procore Technologies |
| PEG Ratio | -1.43 | -0.36 | Life |
| EV/EBITDA | 410.74 | -98.28 | Procore Technologies |
| Profit Margin (TTM) | 6.45% | -11.58% | Life |
| Operating Margin (TTM) | 1.73% | -9.04% | Life |
| EBITDA Margin (TTM) | 1.73% | N/A | N/A |
| Return on Equity | 7.95% | -11.54% | Life |
| Return on Assets (TTM) | 0.55% | -5.22% | Life |
| Free Cash Flow (TTM) | $27.48M | $127.50M | Procore Technologies |
| 1-Year Return | 114.14% | 5.34% | Life |
| Price-to-Sales Ratio (TTM) | 15.82 | 8.06 | Procore Technologies |
| Enterprise Value | $6.63B | $9.38B | Procore Technologies |
| EV/Revenue Ratio | 15.52 | 7.61 | Procore Technologies |
| Gross Profit Margin (TTM) | 78.44% | 79.09% | Procore Technologies |
| Revenue per Share (TTM) | $2 | $8 | Procore Technologies |
| Earnings per Share (Diluted) | $0.38 | $-0.97 | Life |
| Beta (Stock Volatility) | 0.98 | 0.90 | Procore Technologies |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Life vs Procore Technologies Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Life | 4.79% | 0.98% | 15.49% | 41.70% | 90.18% | 105.71% |
| Procore Technologies | 4.82% | 0.03% | -11.92% | -3.91% | -21.36% | -13.96% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Life | 114.14% | 217.50% | 217.50% | 1,314.94% | 1,314.94% | 1,314.94% |
| Procore Technologies | 5.34% | 19.60% | -27.01% | -27.01% | -27.01% | -27.01% |
Performance & Financial Health Analysis: Life vs Procore Technologies
| Metric | LIF | PCOR |
|---|---|---|
| Market Information | ||
| Market Cap | $6.76B | $9.93B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,007,550 | 2,353,690 |
| 90 Day Avg. Volume | 821,883 | 2,041,307 |
| Last Close | $90.30 | $67.80 |
| 52 Week Range | $29.62 - $91.25 | $52.78 - $88.92 |
| % from 52W High | -1.04% | -23.75% |
| All-Time High | $91.25 (Aug 22, 2025) | $108.75 (Aug 02, 2021) |
| % from All-Time High | -1.04% | -37.66% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.36% | 0.14% |
| Quarterly Earnings Growth | 0.36% | 0.14% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | -0.12% |
| Operating Margin (TTM) | 0.02% | -0.09% |
| Return on Equity (TTM) | 0.08% | -0.12% |
| Debt to Equity (MRQ) | 84.50 | 5.94 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.58 | $8.11 |
| Cash per Share (MRQ) | $5.59 | $4.13 |
| Operating Cash Flow (TTM) | $44.06M | $165.19M |
| Levered Free Cash Flow (TTM) | $21.34M | $134.98M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Life vs Procore Technologies
| Metric | LIF | PCOR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 229.47 | -89.09 |
| Forward P/E | -3,946.00 | 54.64 |
| PEG Ratio | -1.43 | -0.36 |
| Price to Sales (TTM) | 15.82 | 8.06 |
| Price to Book (MRQ) | 55.29 | 8.15 |
| Market Capitalization | ||
| Market Capitalization | $6.76B | $9.93B |
| Enterprise Value | $6.63B | $9.38B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 15.52 | 7.61 |
| Enterprise to EBITDA | 410.74 | -98.28 |
| Risk & Other Metrics | ||
| Beta | 0.98 | 0.90 |
| Book Value per Share (MRQ) | $1.58 | $8.11 |
Financial Statements Comparison: Life vs Procore Technologies
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LIF | PCOR |
|---|---|---|
| Revenue/Sales | $115.38M | $310.63M |
| Cost of Goods Sold | $24.88M | $64.93M |
| Gross Profit | $90.50M | $245.71M |
| Research & Development | $32.26M | $87.61M |
| Operating Income (EBIT) | $1.99M | $-36.25M |
| EBITDA | $3.88M | $-555,000 |
| Pre-Tax Income | $6.61M | $-27.70M |
| Income Tax | $-392,000 | $5.29M |
| Net Income (Profit) | $7.01M | $-32.99M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LIF | PCOR |
|---|---|---|
| Cash & Equivalents | $168.85M | $313.73M |
| Total Current Assets | $250.11M | $816.49M |
| Total Current Liabilities | $74.03M | $685.60M |
| Long-Term Debt | $263,000 | $64.50M |
| Total Shareholders Equity | $376.28M | $1.18B |
| Retained Earnings | $-285.32M | $-1.28B |
| Property, Plant & Equipment | $2.04M | $96.45M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LIF | PCOR |
|---|---|---|
| Operating Cash Flow | $22.85M | $87.25M |
| Capital Expenditures | $-124,000 | $-4.03M |
| Free Cash Flow | $10.54M | $46.66M |
| Debt Repayment | N/A | $-388,000 |
| Common Stock Repurchase | N/A | $-100.03M |
Short Interest & Institutional Ownership Analysis
| Metric | LIF | PCOR |
|---|---|---|
| Shares Short | 3.54M | 12.02M |
| Short Ratio | 4.71 | 8.70 |
| Short % of Float | 0.05% | 0.12% |
| Average Daily Volume (10 Day) | 1,007,550 | 2,353,690 |
| Average Daily Volume (90 Day) | 821,883 | 2,041,307 |
| Shares Outstanding | 75.40M | 149.85M |
| Float Shares | 73.81M | 136.82M |
| % Held by Insiders | 0.02% | 0.09% |
| % Held by Institutions | 0.27% | 0.95% |
Dividend Analysis & Yield Comparison: Life vs Procore Technologies
| Metric | LIF | PCOR |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |